Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital

Microbial Drug Resistance

Volumn 22, Issue 5, 2016, Pages 392-398

  Mavroidi, Angeliki ^a   Katsiari, Maria ^a   Likousi, Sofia ^a   Palla, Eleftheria ^a   Roussou, Zoi ^a   Nikolaou, Charikleia ^a   Maguina, Asimina ^a   Platsouka, Evangelia D ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; MEMBRANE PROTEIN; TRANSPOSON;

AMPLICON; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; BACTERIUM ISOLATE; COLISTIN RESISTANT CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; CONTROLLED STUDY; ENDEMIC DISEASE; GENERAL HOSPITAL; GENOTYPE; GREECE; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; AGED; CLASSIFICATION; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; TRANSPOSON; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; GENE EXPRESSION; GREECE; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; SEQUENCE ANALYSIS, DNA;

EID: 84978229568     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0282     Document Type: Article

References (28)

1. Antoniadou, A., F. Kontopidou, G. Poulakou, E. Koratzanis, I. Galani, E. Papadomichelakis, P. Kopterides, M. Souli, A. Armaganidis, and H. Giamarellou. 2007. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J. Antimicrob. Chemother. 59:786-790
2. Bogdanovich, T., J.M. Adams-Haduch, G.B. Tian, M.H. Nguyen, E.J. Kwak, C.A. Muto, and Y. Doi. 2011. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin. Infect Dis. 53: 373-376
3. Bush, K. 2013. Carbapenemases: partners in crime. J. Global Antimicrob. Resist. 1:7-16
4. Cannatelli, A., M.M. D'Andrea, T. Giani, V. Di Pilato, F. Arena, S. Ambretti, P. Gaibani, and G.M. Rossolini. 2013. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemase mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob. Agents Chemother. 57:5521-5526
5. Cannatelli, A., T. Giani, M.M. D'Andrea, V. Di Pilato, F. Arena, V. Conte, K. Tryfinopoulou, A. Vatopoulos, G.M. Rossolini; the COLGRIT Study Group. 2014. MgrB inactivation is a commonmechanismof colistin resistance inKPC carbapenemase-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58:5696-5703
6. Canton, R., M. Akova, Y. Carmeli, C.G. Giske, Y. Glupczynski, M. Gniadkowski, D.M. Livermore, V. Miriagou, T. Naas, G.M. Rossolini, O. Samuelsen, H. Seifert, N. Woodford, P. Nordmann; European Network on Carbapenemases. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18:413-431
7. Capone, A., M. Giannella, D. Fortini, A. Giordano, M. Meledandri, M. Ballardini, M. Venditti, E. Bordi, D. Capozzi, M.P. Balice, A. Tarasi, G. Parisi, A. Lappa, A. Carattoli, N. Petrosillo; the SEERBIO-GRAB Network. 2013. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin. Microbiol. Infection. 19:E23-E30
8. Clinical and Laboratory Standards Institute. 2014. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement. M100-S24. Wayne, PA, USA
9. Diancourt, L., V. Passet, J. Verhoef, P.A. Grimont, and S. Brisse. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43: 4178-4182
10. Giakkoupi, P., H. Maltezou, M. Polemis, O. Pappa, G. Saroglou, A. Vatopoulos; the Greek System for the Surveillance of Antimicrobial Resistance. 2009. Greek system for the surveillance of antimicrobial resistance. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 14: 19218
11. Giakkoupi, P., C.C. Papagiannitsis, V. Miriagou, O. Pappa, M. Polemis, K. Tryfinopoulou, L.S. Tzouvelekis, and A.C. Vatopoulos. 2011. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J. Antimicrob. Chemother. 6:1510-1513
12. Horan, T.C., M. Andrus, and M.A. Dudeck. 2008. CDC/ NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332
13. Jayol A., L. Poirel, A. Brink, M.V. Villegas, M. Yilmaz, and P. Nordmann. 2014. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58:4762-4766
14. Katsiari, M., P. Giakkoupi, S. Likousi, Z. Roussou, M. Polemis, A.C. Vatopoulos, E.D. Platsouka, and A. Maguina. 2015. Carbapenem-resistant Klebsiella pneumoniae infections in Greek intensive care unit: molecular characterisation and treatment challenges. J. Global Antimicrob. Resist. 3:123-127
15. Monaco, M., T. Giani, M. Raffone, F. Arena, A. Garcia-Fernandez, S. Pollini, the Network EuSCAPE-Italy, H. Grundmann, A. Pantosti, and G.M. Rossolini. 2014. Colistin resistance superimposed to endemic carbapenemresistant Klebsiella pneumoniae: a rapidly evolving in Italy, November 2013 to April 2014. Euro Surveill. 19:20939
16. Papadimitriou-Olivgeris, M., M. Christofidou, F. Fligou, C. Bartzavali, T. Vrettos, K.S. Filos, M. Marangos, and E.D. Anastassiou. 2014. The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 42:883-890
17. Papagiannitsis, C.C., K. Tryfinopoulou, P. Giakkoupi, O. Pappa, M. Polemis, E. Tzelepi, L.S. Tzouvelekis, the Carbapenemase Study Group, and A.C. Vatopoulos. 2012. Diversity of acquired b-lactamases amongst Klebsiella pneumoniae in Greek hospitals. Int. J. Antimicrob. Agents 39:178-180
18. Patel, G., S. Huprikar, S.H. Factor, S.G. Jenkins, and D.P. Calfee. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29:1099-1106
19. Poirel, L., A. Jayol, S. Bontron, M.V. Villegas, M. Ozdamar, S. Turkoglu, and P. Nordmann. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70:75-80
20. Snitkin, E.S., A.M. Zelazny, P.J. Thomas, F. Stock, NISC Comparative Sequencing Program, D.K. Henderson, T.N. Palmore, and J. A. Segre. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci. Transl. Med. 4:148ra116
21. Suh, J.Y., J.S. Son, D.R. Chung, K.R. Peck, K.S. Ko, and J.H. Song. 2010. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob. Agents Chemother. 54:560-562
22. Toth, A ., I. Damjanova, E. Puskas, L. Janvari, M. Farkas, A. Dobak, K. Borocz, and J. Pazsti. 2010. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur. J. Clin. Microbiol. Infect. Dis. 29:765-769
23. Tsakris, A., K. Themeli-Digalaki, A. Poulou, G. Vrioni, E. Voulgari, V. Koumaki, A. Agodi, S. Pournaras, and D. Sofianou. 2011. Comparative evaluation of combineddisk tests using different boronic acid compounds for detection of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae clinical isolates. J. Clin. Microbiol. 49: 2804-2809
24. Tzouvelekis, L.S., A. Markogiannakis, M. Psichogiou, P.T. Tassios, and G.L. Daikos. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707
25. van Duin, D., and Y. Doi. 2015. Outbreak of colistinresistant KPC-producing Klebsiella pneumoniae: are we at the end of the road? J. Clin. Microbiol. 53:3116-3117
26. Vatopoulos, A. 2008. High rates of metallo-betalactamase-producing Klebsiella pneumoniae in Greece-A review of the current evidence. Euro Surveill. 13:8023
27. Weterings, V., K. Zhou, J.W. Rossen, D. van Stenis, E. Thewessen, J. Kluytman, and J. Veenemans. 2015. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands ( July to December 2013), with inter-institutional spread. Eur. J. Clin. Microbiol. Infect. Dis. 34:1647-1655
28. Woodford, N., J.F. Turton, and D.M. Livermore. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755